» Articles » PMID: 30228981

Respiratory Tract Infection: A Risk Factor for the Onset and Relapse of Adult-Onset Minimal Change Disease in Southern China

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2018 Sep 20
PMID 30228981
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Aims/introduction: Steroid resistance and frequent relapse are problems in the treatment of minimal change disease (MCD). However, epidemiological factors that influence steroid-resistant and relapse of MCD are rarely reported. This study evaluated potential factors that influence the onset and relapse of MCD and the epidemiological features of southern Chinese patients with adult-onset MCD.

Patients And Methods: Patients with adult-onset MCD were included from the Affiliated Hospital of Guangdong Medical University, which is located in the southernmost part of China's mainland, between 2015 and 2016. Potential influencing factors were investigated.

Results: Eighty-seven patients with incipient MCD were enrolled, and 85 of these patients were followed up; 71.8% (61/85) were steroid-sensitive and 28.2% (24/85) were steroid-resistant. In terms of seasonal distribution, the highest rate of incipient cases was in spring (39.1%, 34/87), which also showed a high rate of relapse cases (29.7%, 22/74). Among patients who were followed up for more than half a year and whose proteinuria completely resolved (69.4%, 59/85), 52.5% (31/59) were without relapse and 47.5% (28/59) were with relapse. Patients without relapse were older than those with relapse (<0.05). Before disease onset, 20.7% (18/87) of patients with incipient MCD were diagnosed with infection, including 94.5% (17/18) with respiratory tract infection. Fourteen patients in complete remission posttreatment developed an infection before relapse, including 85.7% (12/14) with respiratory tract infection.

Conclusion: Steroid resistance and frequent relapse are current challenges for the treatment of adult-onset MCD in southern China, and respiratory tract infection may be a risk factor for onset and relapse. Additionally, younger patients with MCD tend to have more frequent relapse.

Citing Articles

Relationship between time to clinical remission and relapse in adults with steroid-sensitive minimal change disease: a retrospective cohort study.

Ye X, Gao S, Shen K, Xiao Z, Liu H, Pan Q Ann Med. 2024; 56(1):2409344.

PMID: 39387505 PMC: 11469425. DOI: 10.1080/07853890.2024.2409344.


Effectiveness of Rituximab and Its Biosimilar in Treating Adult Steroid-Dependent Minimal Change Disease and Relapse.

Shan H Cureus. 2023; 15(11):e49200.

PMID: 38130516 PMC: 10735323. DOI: 10.7759/cureus.49200.


The expression of respiratory tract virus in pediatric glomerular disease: a retrospective study of 45 renal biopsy in China.

Lin L, Li L, Cao Y, Peng X, Wu Y, Yu P BMC Nephrol. 2023; 24(1):36.

PMID: 36792980 PMC: 9931563. DOI: 10.1186/s12882-023-03083-8.


Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study.

Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Takeda A J Nephrol. 2022; 35(4):1135-1144.

PMID: 35366214 DOI: 10.1007/s40620-022-01279-z.


Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome.

Turolo S, Edefonti A, Mazzocchi A, Syren M, Morello W, Agostoni C Int J Mol Sci. 2021; 22(11).

PMID: 34064238 PMC: 8196840. DOI: 10.3390/ijms22115452.


References
1.
Abdel-Hafez M, Shimada M, Lee P, Johnson R, Garin E . Idiopathic nephrotic syndrome and atopy: is there a common link?. Am J Kidney Dis. 2009; 54(5):945-53. PMC: 2895907. DOI: 10.1053/j.ajkd.2009.03.019. View

2.
Shinzawa M, Yamamoto R, Nagasawa Y, Oseto S, Mori D, Tomida K . Age and prediction of remission and relapse of proteinuria and corticosteroid-related adverse events in adult-onset minimal-change disease: a retrospective cohort study. Clin Exp Nephrol. 2013; 17(6):839-47. DOI: 10.1007/s10157-013-0793-9. View

3.
Franke I, Aydin M, Lopez C, Kurylowicz L, Ganschow R, Lentze M . The incidence of the nephrotic syndrome in childhood in Germany. Clin Exp Nephrol. 2017; 22(1):126-132. DOI: 10.1007/s10157-017-1433-6. View

4.
Palmer S, Nand K, Strippoli G . Interventions for minimal change disease in adults with nephrotic syndrome. Cochrane Database Syst Rev. 2008; (1):CD001537. PMC: 7025787. DOI: 10.1002/14651858.CD001537.pub4. View

5.
Wakasugi M, Kazama J, Narita I . Premature mortality due to nephrotic syndrome and the trend in nephrotic syndrome mortality in Japan, 1995-2014. Clin Exp Nephrol. 2017; 22(1):55-60. DOI: 10.1007/s10157-017-1417-6. View